Base nitric oxide level in saliva in patients with COPD

G. L. Ignatova, L. A. Stepanisheva, S. N. Teplova, J. N. Mikryukova, E. R. Zvenjatskaya (Chelyabinsk, Russian Federation)

Source: Annual Congress 2005 - Asthma and rhinitis: insight from airway secretions and exhaled air
Session: Asthma and rhinitis: insight from airway secretions and exhaled air
Session type: Poster Discussion
Number: 4681
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. L. Ignatova, L. A. Stepanisheva, S. N. Teplova, J. N. Mikryukova, E. R. Zvenjatskaya (Chelyabinsk, Russian Federation). Base nitric oxide level in saliva in patients with COPD. Eur Respir J 2005; 26: Suppl. 49, 4681

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006

Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008



Exhaled nitric oxide (NO) in patients with chronic cough
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004

Serum nitric oxide metabolists in bronchial asthma patients
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008

Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004

Serum nitrotyrosine and nitric oxide levels in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002

Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010


Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 434s
Year: 2002

An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003



Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007

Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005

The influence of spirometry on the level of exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 569s
Year: 2003

Who are the children with increased faractional exhaled nitric oxide?
Source: Virtual Congress 2020 – Paediatric asthma
Year: 2020